SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001060736-22-000036
Filing Date
2022-04-28
Accepted
2022-04-28 16:04:26
Documents
14
Period of Report
2022-04-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sgen-20220428.htm   iXBRL 8-K 35229
2 EX-99.1 ex-9912022q1.htm EX-99.1 110202
6 imagea.jpg GRAPHIC 187351
  Complete submission text file 0001060736-22-000036.txt   556004

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgen-20220428.xsd EX-101.SCH 1995
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgen-20220428_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgen-20220428_pre.xml EX-101.PRE 12591
8 EXTRACTED XBRL INSTANCE DOCUMENT sgen-20220428_htm.xml XML 10803
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 22866426
SIC: 2836 Biological Products, (No Diagnostic Substances)